Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Minireview: Obesity and breast cancer: the estrogen connection.

Cleary MP, Grossmann ME.

Endocrinology. 2009 Jun;150(6):2537-42. doi: 10.1210/en.2009-0070. Epub 2009 Apr 16. Review.

2.

Obesity and Breast Cancer.

Fortner RT, Katzke V, Kühn T, Kaaks R.

Recent Results Cancer Res. 2016;208:43-65. Review.

PMID:
27909901
3.

Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status.

Munsell MF, Sprague BL, Berry DA, Chisholm G, Trentham-Dietz A.

Epidemiol Rev. 2014;36:114-36. doi: 10.1093/epirev/mxt010. Review.

4.

Obesity, inflammation, and postmenopausal breast cancer: therapeutic implications.

Macciò A, Madeddu C.

ScientificWorldJournal. 2011;11:2020-36. doi: 10.1100/2011/806787. Epub 2011 Oct 27. Review.

5.
6.

Breast cancer and obesity: an update.

Stephenson GD, Rose DP.

Nutr Cancer. 2003;45(1):1-16. Review.

PMID:
12791499
7.

Body fat distribution and obesity in pre- and postmenopausal breast cancer.

Sonnenschein E, Toniolo P, Terry MB, Bruning PF, Kato I, Koenig KL, Shore RE.

Int J Epidemiol. 1999 Dec;28(6):1026-31.

PMID:
10661643
8.

Breast cancer risk in the WHI study: the problem of obesity.

Kuhl H.

Maturitas. 2005 May 16;51(1):83-97. Review.

PMID:
15883113
9.

Interaction between menopausal status and obesity in affecting breast cancer risk.

Rose DP, Vona-Davis L.

Maturitas. 2010 May;66(1):33-8. doi: 10.1016/j.maturitas.2010.01.019. Epub 2010 Feb 23. Review.

PMID:
20181446
10.

Sex hormones and breast cancer risk and prognosis.

Folkerd E, Dowsett M.

Breast. 2013 Aug;22 Suppl 2:S38-43. doi: 10.1016/j.breast.2013.07.007. Review.

PMID:
24074790
11.

The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer.

Cleary MP, Maihle NJ.

Proc Soc Exp Biol Med. 1997 Oct;216(1):28-43. Review.

PMID:
9316608
12.

Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.

Krajcik RA, Borofsky ND, Massardo S, Orentreich N.

Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1566-73.

13.
14.

Influence of obesity on breast cancer receptor status and prognosis.

Rose DP, Vona-Davis L.

Expert Rev Anticancer Ther. 2009 Aug;9(8):1091-101. doi: 10.1586/era.09.71. Review.

PMID:
19671029
15.

Control of body weight versus tumorigenesis by concerted action of leptin and estrogen.

He Z, Feng GS.

Rev Endocr Metab Disord. 2013 Dec;14(4):339-45. doi: 10.1007/s11154-013-9277-1. Review.

PMID:
24142297
16.

Breast cancer and obesity.

La Guardia M, Giammanco M.

Panminerva Med. 2001 Jun;43(2):123-33. Review.

PMID:
11449184
17.

Alcohol promotes mammary tumor development via the estrogen pathway in estrogen receptor alpha-negative HER2/neu mice.

Wong AW, Dunlap SM, Holcomb VB, Nunez NP.

Alcohol Clin Exp Res. 2012 Apr;36(4):577-87. doi: 10.1111/j.1530-0277.2011.01654.x. Epub 2011 Oct 7.

PMID:
21981381
18.

[Estrogen intracrinology: therapy and chemoprevention of breast cancer].

Licznerska B, Baer-Dubowska W.

Postepy Hig Med Dosw (Online). 2010 May 19;64:220-30. Review. Polish.

19.

Reduced progesterone levels explain the reduced risk of breast cancer in obese premenopausal women: a new hypothesis.

Dowsett M, Folkerd E.

Breast Cancer Res Treat. 2015 Jan;149(1):1-4. doi: 10.1007/s10549-014-3211-4. Epub 2014 Nov 21. Review.

PMID:
25414027
20.

Adiposity and sex hormones in postmenopausal breast cancer survivors.

McTiernan A, Rajan KB, Tworoger SS, Irwin M, Bernstein L, Baumgartner R, Gilliland F, Stanczyk FZ, Yasui Y, Ballard-Barbash R.

J Clin Oncol. 2003 May 15;21(10):1961-6.

Supplemental Content

Support Center